Takeda Pharmaceutical (TAK): Officer sold ~$974K

~$974K

Approx. value · 47K sh @ $20.89

215K

Holds after · shares reported

Traded

Nov 2, 2026

Filed

Nov 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 2, 2026 · this disclosureInsiderOfficer sold ~$974K of TAK shares in the open market

What came next

1. Nov 4, 2026InsiderOfficer sold ~$1.16M of TAK shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Takeda Pharmaceutical

For Takeda Pharmaceutical, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TAK page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Takeda Pharmaceutical

• SEC Form 4Nov 5, 2026
• SEC Form 144Oct 30, 2026
• SEC Form 144Oct 30, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 11, 2026

Everything OQRO holds on this company is on its TAK page.